US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist

3.400
+0.110+3.34%

Close Apr 26 16:00 ET

3.400
0.0000.00%

Post 16:20 ET

354.33MMarket Cap-887P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

76.55%234.04M

39.82%69.8M

95.68%56.78M

104.93%58.13M

95.29%49.33M

70.40%132.57M

92.37%49.92M

46.95%29.02M

50.86%28.37M

89.95%25.26M

Operating revenue

76.55%234.04M

39.82%69.8M

95.68%56.78M

104.93%58.13M

95.29%49.33M

70.40%132.57M

92.37%49.92M

46.95%29.02M

50.86%28.37M

89.95%25.26M

Cost of revenue

43.93%74.36M

-25.70%17.47M

80.82%19.41M

123.74%21.31M

104.88%16.17M

120.70%51.67M

198.38%23.52M

82.40%10.74M

75.51%9.52M

87.17%7.89M

Gross profit

97.38%159.68M

98.16%52.33M

104.40%37.36M

95.42%36.83M

90.93%33.16M

48.74%80.9M

46.14%26.41M

31.89%18.28M

40.87%18.85M

91.24%17.37M

Operating expense

8.20%382.01M

4.68%105.75M

-13.60%82.74M

33.43%102.33M

14.58%91.19M

7.29%353.07M

26.80%101.03M

10.60%95.76M

-8.40%76.69M

0.63%79.59M

Selling and administrative expenses

33.02%292.24M

31.32%84.3M

4.62%67.73M

63.03%76.34M

45.35%63.87M

10.50%219.7M

30.20%64.19M

25.05%64.74M

-5.74%46.83M

-8.60%43.94M

-Selling and marketing expense

38.41%253.42M

----

--183.1M

----

-General and administrative expense

6.06%38.81M

-42.23%-169.13M

4.62%67.73M

63.03%76.34M

45.35%63.87M

--36.6M

---118.91M

25.05%64.74M

-5.74%46.83M

-8.60%43.94M

Research and development costs

-21.60%79.41M

4.22%20.37M

-49.97%13.06M

-8.45%22.81M

-24.58%23.18M

-12.88%101.29M

-33.69%19.54M

-13.26%26.1M

-15.38%24.91M

12.76%30.73M

Depreciation amortization depletion

-67.70%10.36M

-93.70%1.09M

-60.33%1.95M

-35.79%3.18M

-15.71%4.15M

129.38%32.09M

1,809.27%17.3M

4.37%4.92M

7.62%4.95M

30.48%4.92M

-Depreciation and amortization

-67.70%10.36M

-93.70%1.09M

-60.33%1.95M

-35.79%3.18M

-15.71%4.15M

129.38%32.09M

1,809.27%17.3M

4.37%4.92M

7.62%4.95M

30.48%4.92M

Operating profit

18.31%-222.34M

28.41%-53.43M

41.43%-45.38M

-13.24%-65.5M

6.73%-58.03M

0.91%-272.17M

-21.13%-74.62M

-6.55%-77.48M

17.76%-57.84M

11.13%-62.22M

Net non-operating interest income expense

47.59%-6.07M

-172.40%-1.96M

76.36%-1.36M

62.52%-1.22M

17.68%-1.53M

-95.13%-11.58M

52.00%-721K

-286.82%-5.75M

-119.34%-3.26M

-26.79%-1.86M

Non-operating interest income

171.62%13.29M

13.30%3.43M

220.43%3.73M

408.56%3.15M

3,807.89%2.97M

1,351.34%4.89M

4,169.01%3.03M

1,286.90%1.17M

628.24%619K

-21.65%76K

Non-operating interest expense

17.49%19.36M

43.87%5.4M

-26.37%5.09M

12.75%4.37M

132.88%4.5M

162.62%16.47M

138.53%3.75M

340.29%6.92M

146.91%3.87M

23.78%1.93M

Other net income (expense)

-32.39%-95.28M

99.56%-310K

-12,335.54%-94.14M

-77.22%-599K

12.03%-234K

-10,210.89%-71.97M

-882,712.50%-70.61M

-356.02%-757K

10.11%-338K

-62.20%-266K

Special income (charges)

-35.33%-94.44M

99.24%-528K

---93.91M

----

---69.79M

--0

----

-Less：Restructuring and merger&acquisition

--1.26M

--528K

--732K

----

--0

----

-Less:Impairment of capital assets

33.52%93.18M

--0

--93.18M

----

--69.79M

--0

----

Other non- operating income (expenses)

61.58%-838K

126.59%218K

70.54%-223K

-77.22%-599K

12.03%-234K

-212.46%-2.18M

-811.11%-820K

-418.49%-757K

5.32%-338K

-153.33%-266K

Income before tax

9.01%-323.69M

61.84%-55.7M

-67.72%-140.88M

-9.58%-67.32M

7.07%-59.79M

-26.45%-355.72M

-131.31%-145.95M

-12.93%-83.99M

14.91%-61.44M

10.19%-64.34M

Income tax

-57.14%300K

-119.57%-64K

700K

327K

Net income

9.10%-323.99M

61.84%-55.7M

-66.69%-141.18M

-8.89%-67.25M

7.07%-59.79M

-26.70%-356.42M

-131.31%-145.95M

-13.87%-84.69M

14.45%-61.76M

10.19%-64.34M

Net income continuous Operations

9.10%-323.99M

61.84%-55.7M

-66.69%-141.18M

-8.89%-67.25M

7.07%-59.79M

-26.70%-356.42M

-131.31%-145.95M

-13.87%-84.69M

14.45%-61.76M

10.19%-64.34M

Minority interest income

Net income attributable to the parent company

9.10%-323.99M

61.84%-55.7M

-66.69%-141.18M

-8.89%-67.25M

7.07%-59.79M

-26.70%-356.42M

-131.31%-145.95M

-13.87%-84.69M

14.45%-61.76M

10.19%-64.34M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

9.10%-323.99M

61.84%-55.7M

-66.69%-141.18M

-8.89%-67.25M

7.07%-59.79M

-26.70%-356.42M

-131.31%-145.95M

-13.87%-84.69M

14.45%-61.76M

10.19%-64.34M

Basic earnings per share

21.84%-3.83

65.38%-0.63

-39.32%-1.63

9.09%-0.8

21.28%-0.74

-17.51%-4.9

-95.70%-1.82

-6.36%-1.17

17.76%-0.88

12.96%-0.94

Diluted earnings per share

21.84%-3.83

65.38%-0.63

-39.32%-1.63

9.09%-0.8

21.28%-0.74

-17.51%-4.9

-95.70%-1.82

-6.36%-1.17

17.76%-0.88

12.96%-0.94

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	76.55%234.04M	39.82%69.8M	95.68%56.78M	104.93%58.13M	95.29%49.33M	70.40%132.57M	92.37%49.92M	46.95%29.02M	50.86%28.37M	89.95%25.26M
Operating revenue	76.55%234.04M	39.82%69.8M	95.68%56.78M	104.93%58.13M	95.29%49.33M	70.40%132.57M	92.37%49.92M	46.95%29.02M	50.86%28.37M	89.95%25.26M
Cost of revenue	43.93%74.36M	-25.70%17.47M	80.82%19.41M	123.74%21.31M	104.88%16.17M	120.70%51.67M	198.38%23.52M	82.40%10.74M	75.51%9.52M	87.17%7.89M
Gross profit	97.38%159.68M	98.16%52.33M	104.40%37.36M	95.42%36.83M	90.93%33.16M	48.74%80.9M	46.14%26.41M	31.89%18.28M	40.87%18.85M	91.24%17.37M
Operating expense	8.20%382.01M	4.68%105.75M	-13.60%82.74M	33.43%102.33M	14.58%91.19M	7.29%353.07M	26.80%101.03M	10.60%95.76M	-8.40%76.69M	0.63%79.59M
Selling and administrative expenses	33.02%292.24M	31.32%84.3M	4.62%67.73M	63.03%76.34M	45.35%63.87M	10.50%219.7M	30.20%64.19M	25.05%64.74M	-5.74%46.83M	-8.60%43.94M
-Selling and marketing expense	38.41%253.42M	----	----	----	----	--183.1M	----	----	----	----
-General and administrative expense	6.06%38.81M	-42.23%-169.13M	4.62%67.73M	63.03%76.34M	45.35%63.87M	--36.6M	---118.91M	25.05%64.74M	-5.74%46.83M	-8.60%43.94M
Research and development costs	-21.60%79.41M	4.22%20.37M	-49.97%13.06M	-8.45%22.81M	-24.58%23.18M	-12.88%101.29M	-33.69%19.54M	-13.26%26.1M	-15.38%24.91M	12.76%30.73M
Depreciation amortization depletion	-67.70%10.36M	-93.70%1.09M	-60.33%1.95M	-35.79%3.18M	-15.71%4.15M	129.38%32.09M	1,809.27%17.3M	4.37%4.92M	7.62%4.95M	30.48%4.92M
-Depreciation and amortization	-67.70%10.36M	-93.70%1.09M	-60.33%1.95M	-35.79%3.18M	-15.71%4.15M	129.38%32.09M	1,809.27%17.3M	4.37%4.92M	7.62%4.95M	30.48%4.92M
Operating profit	18.31%-222.34M	28.41%-53.43M	41.43%-45.38M	-13.24%-65.5M	6.73%-58.03M	0.91%-272.17M	-21.13%-74.62M	-6.55%-77.48M	17.76%-57.84M	11.13%-62.22M
Net non-operating interest income expense	47.59%-6.07M	-172.40%-1.96M	76.36%-1.36M	62.52%-1.22M	17.68%-1.53M	-95.13%-11.58M	52.00%-721K	-286.82%-5.75M	-119.34%-3.26M	-26.79%-1.86M
Non-operating interest income	171.62%13.29M	13.30%3.43M	220.43%3.73M	408.56%3.15M	3,807.89%2.97M	1,351.34%4.89M	4,169.01%3.03M	1,286.90%1.17M	628.24%619K	-21.65%76K
Non-operating interest expense	17.49%19.36M	43.87%5.4M	-26.37%5.09M	12.75%4.37M	132.88%4.5M	162.62%16.47M	138.53%3.75M	340.29%6.92M	146.91%3.87M	23.78%1.93M
Other net income (expense)	-32.39%-95.28M	99.56%-310K	-12,335.54%-94.14M	-77.22%-599K	12.03%-234K	-10,210.89%-71.97M	-882,712.50%-70.61M	-356.02%-757K	10.11%-338K	-62.20%-266K
Special income (charges)	-35.33%-94.44M	99.24%-528K	---93.91M	----	----	---69.79M	---69.79M	--0	----	----
-Less：Restructuring and merger&acquisition	--1.26M	--528K	--732K	----	----	--0	--0	--0	----	----
-Less:Impairment of capital assets	33.52%93.18M	--0	--93.18M	----	----	--69.79M	--69.79M	--0	----	----
Other non- operating income (expenses)	61.58%-838K	126.59%218K	70.54%-223K	-77.22%-599K	12.03%-234K	-212.46%-2.18M	-811.11%-820K	-418.49%-757K	5.32%-338K	-153.33%-266K
Income before tax	9.01%-323.69M	61.84%-55.7M	-67.72%-140.88M	-9.58%-67.32M	7.07%-59.79M	-26.45%-355.72M	-131.31%-145.95M	-12.93%-83.99M	14.91%-61.44M	10.19%-64.34M
Income tax	-57.14%300K	0	-57.14%300K	-119.57%-64K		700K	0	700K	327K
Net income	9.10%-323.99M	61.84%-55.7M	-66.69%-141.18M	-8.89%-67.25M	7.07%-59.79M	-26.70%-356.42M	-131.31%-145.95M	-13.87%-84.69M	14.45%-61.76M	10.19%-64.34M
Net income continuous Operations	9.10%-323.99M	61.84%-55.7M	-66.69%-141.18M	-8.89%-67.25M	7.07%-59.79M	-26.70%-356.42M	-131.31%-145.95M	-13.87%-84.69M	14.45%-61.76M	10.19%-64.34M
Minority interest income
Net income attributable to the parent company	9.10%-323.99M	61.84%-55.7M	-66.69%-141.18M	-8.89%-67.25M	7.07%-59.79M	-26.70%-356.42M	-131.31%-145.95M	-13.87%-84.69M	14.45%-61.76M	10.19%-64.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	9.10%-323.99M	61.84%-55.7M	-66.69%-141.18M	-8.89%-67.25M	7.07%-59.79M	-26.70%-356.42M	-131.31%-145.95M	-13.87%-84.69M	14.45%-61.76M	10.19%-64.34M
Basic earnings per share	21.84%-3.83	65.38%-0.63	-39.32%-1.63	9.09%-0.8	21.28%-0.74	-17.51%-4.9	-95.70%-1.82	-6.36%-1.17	17.76%-0.88	12.96%-0.94
Diluted earnings per share	21.84%-3.83	65.38%-0.63	-39.32%-1.63	9.09%-0.8	21.28%-0.74	-17.51%-4.9	-95.70%-1.82	-6.36%-1.17	17.76%-0.88	12.96%-0.94
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall